Please login to the form below
US Department of Justice
This page shows the latest US Department of Justice news and features for those working in and with pharma, biotech and healthcare.
Teva reaches $925,000 settlement to resolve drug price-fixing claims
Last year, the US Department of Justice charged Teva for conspiring with competitors in a generic drug price-fixing probe. ... Then, last year, the US Department of Justice (DoJ) charged Teva for conspiring with competitors in a generic drug
Latest news
-
Purdue to pay over $8bn to settle opioid-related criminal claims
Purdue Pharma has reached an $8m+ settlement with the US Department of Justice to avoid federal civil and criminal charges related to claims it helped fuel the country’s opioid epidemic. ... today’s announcement re-affirms that the Department of
-
US charges Teva for generic drug price-fixing plot
Company maintains it has not committed any wrongdoing. The US Department of Justice (DoJ) has charged Teva Pharmaceuticals for conspiring with competitors in a generic drugs price-fixing probe. ... In May last year, a wide-ranging lawsuit was filed in
-
Ex-Sandoz exec admits role in generic drug price-fixing plot
Reignites criticism of high drug prices in the US. Former Sandoz executive Hector Armando Kellum has pled guilty to charges levied against him, which allege he participated in a price-fixing ... Although these two medicines were the only ones
-
Teva among generic drugmakers hoping to settle US antitrust probe
Teva Pharmaceuticals is among one of a number of generic drugmakers allegedly looking to resolve a criminal antitrust probe initiated by the US Department of Justice, according to Bloomberg. ... Back in August, US politicians also accused Teva,
-
Avanir’s week goes from bad to worse with Alzheimer’s stumble
The US Department of Justice said on Friday that Avanir had encouraged prescribing of Nuedexta for unapproved uses, including agitation in AD, and took advantage of a drive to reduce the ... Otsuka paid $3.5bn to acquire Avanir in 2014 as part of a
More from news
Approximately 4 fully matching, plus 47 partially matching documents found.
Latest Intelligence
-
Will biosimilars ever catch on in the US?
As prices in the US continue to spiral out of control, we can only look on with envy. ... Department of Justice.
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
Its share price took a massive hit when it was indicted by the US Justice Department earlier this year over its Suboxone Film therapy for opioid and heroin addiction, but its ... Pipeline provides hope. Indivior is fighting the Department of Justice
-
Cybersecurity
Generally the draft Regulation will not change this approach. One method of seeking to meet the adequacy requirement when transferring personal data to the US (which is not an approved country ... test). Following the decision in the Schrems case last
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- A creative awakening – how pharma is bringing innovation to the patient journey
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- The pharma dichotomy
- Our Top 5 Pharma Picks From Cannes Lions
- Live Webinar: Streamlining the Drug Development Process to Transform Global Health
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Pfizer, Mylan move ahead with generics merger and spin-out
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- Roche shares new positive Ocrevus data for MS patients
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
